[ad_1]
Ireland recorded another 379 new Covid-19 cases in the past 24 hours, along with 12 more deaths.
The latest figures for the country were released tonight in a statement from the National Public Health Emergency Team.
In total, 69,058 confirmed cases have been registered in the Republic, while the death toll now stands at 2,006.
Of those included in the latest number of infections, 174 were men and 203 women.
The average age was 36 years, while 64% of new cases were registered in people under 45 years of age.
The news comes ahead of the crucial talks between NPHET and the government next week, which will finally decide the nation’s fate for the holiday season.
But despite the good news that outlets are likely to be allowed to reopen, the medical director warned he is “increasingly concerned” about the increase in cases in several counties in recent days.
(Image: Colin Keegan / Collins)
Dr. Tony Holohan said: “I am increasingly concerned that the positive trends that we have seen recently have not been sustained.
“The 5-day moving average of daily cases has increased from an average of 350 cases on November 11 to 424 today.
“We have two weeks to continue our efforts to reduce community transmission of this disease as much as possible. The lower the incidence, the more flexibility the country will have to make measures more flexible.”
Sign up for our newsletter today!
Just insert your email in the box at the top of this article (this will not work while using the Irish Mirror app) and get the latest news and entertainment directly for you
Every day we will send you an email summary with the latest news. Local Irish news, UK and international news, local and national sports and entertainment news, all in one convenient email.
You can unsubscribe from this service at any time. And rest assured that your data will not be shared with any other party.
Meanwhile, in some positive news, Pfizer has revealed that the final results of the last stage of the trial of its Covid-19 vaccine show that it is 95% effective.
The drug maker said the efficacy of the vaccine developed with German partner BioNTech SE was consistent across age and ethnic demographics, and there were no major side effects, a sign that immunization could be used widely across the world. world.
[ad_2]